Mylan Latest To Feel DOJ Heat Over Generics Price Hikes

The U.S. Department of Justice's probe into skyrocketing generic-drug prices expanded even further Friday, with Mylan revealing the agency has subpoenaed the drugmaker about the marketing, pricing and sale of its...

Already a subscriber? Click here to view full article